Modified cancer-killing virus avoids triggering immune system response

Viruses largely get a bad rap, but some may be helpful. Oncolytic viruses selectively hunt down and kill cancer cells, but this emerging therapy can be rendered ineffective or even dangerous if it alerts the immune system. Now scientists have tweaked t… Continue reading Modified cancer-killing virus avoids triggering immune system response

Experimental cancer vaccine passes animal tests, moves to human trials

A novel cancer vaccine is moving to Phase 1 human trials in the United States after promising results from animal studies showed encouraging efficacy and a robust safety profile. A new study describes the vaccine as producing complete responses in 90 p… Continue reading Experimental cancer vaccine passes animal tests, moves to human trials

New evidence of gut-brain mechanism involved in MS flare-ups

New research, led by a team from UC San Francisco, has shown how immune cells produced in the gut play a protective role during multiple sclerosis (MS) flare-ups. For the first time, scientists have shown how these immune cells travel up to the brain a… Continue reading New evidence of gut-brain mechanism involved in MS flare-ups

“ImmunoBait” particles surf blood cells to fight metastatic lung tumors

Cancer has an unfortunate and often deadly tendency to spread through the body, and the most common location for secondary tumors to appear is the lungs. Now, scientists at Harvard’s Wyss Institute have developed a way to treat metastatic tumors in the… Continue reading “ImmunoBait” particles surf blood cells to fight metastatic lung tumors

Russia claims COVID-19 vaccine success, mass vaccinations may begin soon

Days after Pfizer revealed the first interim Phase 3 trial data for any COVID-19 vaccine, Russian authorities have announced their vaccine candidate is also demonstrating promising results. Experts are calling the Russian data encouraging, but also cau… Continue reading Russia claims COVID-19 vaccine success, mass vaccinations may begin soon

First Phase 3 COVID-19 vaccine trial data is promising, but hurdles remain

Pharmaceutical companies Pfizer and BioTech have announced the first data from their Phase 3 COVID-19 vaccine trial, claiming the experimental mRNA candidate is more than 90 percent effective in preventing symptomatic disease. Experts point out these i… Continue reading First Phase 3 COVID-19 vaccine trial data is promising, but hurdles remain

Wound-healing hydrogel reduces scars by triggering immune response

Scar tissue is an effective short-term solution to quickly patch up wounded skin, but it’s not so great long-term. Now, researchers at Duke University and UCLA have created a new hydrogel that can trigger a regenerative immune response, helping skin he… Continue reading Wound-healing hydrogel reduces scars by triggering immune response

Immune cells discovered protecting the brain are trained in the gut

A new study, published in the prestigious journal Nature, is describing the surprising discovery of a previously unknown gut-brain link. The research reveals certain immune cells that inhabit a protective membrane surrounding the brain actually origina… Continue reading Immune cells discovered protecting the brain are trained in the gut

Massive UK study finds coronavirus antibodies wane over several months

UK researchers are suggesting levels of antibodies produced by the immune system in response to SARS-CoV-2 may significantly drop in the months following an initial infection. Testing hundreds of thousands of subjects over three months, a study saw the… Continue reading Massive UK study finds coronavirus antibodies wane over several months

Immune cell discovery offers hope of reversing neurodegenerative disease

A promising new study, published in the journal Nature Immunology, is describing the discovery of a novel kind of immune cell with the apparent ability to not only prevent the progressive neurological degeneration associated with diseases such as multi… Continue reading Immune cell discovery offers hope of reversing neurodegenerative disease